United States · Investor

Thomas, McNerney & Partners

Last cheque observed Oct 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firmWebsite unconfirmed

GrowthPre-seedSeedConsumerFinTechFinance & Crypto

Cheques on record
0%of best year0cheques in 12 months, 33 on record
Since the last cheque4396days00hrs00min00sec
Median round$17MRounds led0 of 33Sole investor2 roundsExits6 from the portfolioMostly inUnited States, 100%
Pitch Thomas, McNerney & Partners

Thomas, McNerney & Partners highlights

  1. 01

    33 rounds on record

  2. 02

    Mostly Venture and Series B: 47% of its rounds

  3. 03

    Sole investor in 2 rounds, median $15M

  4. 04

    6 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
GrowthPre-seedSeedSeries ASeries B
Sectors
ConsumerFinTechFinance & Crypto
Based in
Stamford, United States
Cold pitches
Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.

The record

Every round we can evidence, newest first33 appearances

  1. 2014

    2 rounds

  2. Oct
    InvitaeSeries F · US$120MWith 13 others
  3. Jan
    Auspex PharmaceuticalsSeries E · US · sec.gov$20MWith 4 others
  4. 2013

    1 round

  5. Jan
    AxioMed SpineSeries D · US · finsmes.com$3.6MWith 4 others
  6. 2012

    5 rounds

  7. Nov
    Auspex PharmaceuticalsSeries D · US · in.finance.yahoo.com$25MWith 3 others
  8. Oct
    CebixSeries C · US · pehub.com$31MWith 2 others
  9. Sept
    Torax MedicalSeries D · US · finsmes.com$30MWith 5 others
  10. Apr
    Tioga PharmaceuticalsSeries B · US · tiogapharma.com$10MWith 1 other
  11. Jan
    SGBSeries B · US · businessreel.com$17MWith 3 others
  12. 2011

    2 rounds

  13. Dec
    InnoPharmaSeries A · US · finsmes.com$15MSole investor
  14. Jun
    CAS Medical SystemsVenture · US · devicespace.com$15MSole investor
  15. 2010

    8 rounds

  16. Oct
    AxioMed SpineSeries D · US · onbiovc.com$15MWith 6 others
  17. Oct
    Auspex PharmaceuticalsSeries C · US · onbiovc.com$12MWith 2 others
  18. Sept
    Celator PharmaceuticalsSeries D · US · celatorpharma.com$20MWith 6 others
  19. Sept
    CebixVenture · US · xconomy.com$16MWith 2 others
  20. Jul
    ZogenixVenture · US · zogenix.com$15MWith 4 others
  21. May
    NeuroTherapeutics PharmaSeries B · US · fiercebiotech.com$43MWith 4 others
  22. Feb
    Altair TherapeuticsSeries B · US · onbiovc.com$17MWith 3 others
  23. Jan
    Intuity MedicalSeries D · US · finsmes.com$64MWith 5 others
  24. 2009

    2 rounds

  25. Nov
    Virdante PharmaceuticalsSeries A · US · onbiovc.com$30MWith 6 others
  26. Oct
    Quinnova PharmaceuticalsSeries B · US · onbiovc.com$17MWith 2 others
  27. 2007

    3 rounds

  28. Nov
    Clarus TherapeuticsSeries C · US$8.0MWith 1 other
  29. Nov
    TranzymeVenture · US$20MWith 3 others
  30. Aug
    Leptos BiomedicalSeries C · US$20MWith 3 others
  31. 2006

    5 rounds

  32. Dec
    Softscope Medical TechnologiesSeries A · US$4.0MWith 1 other
  33. Dec
    Galil MedicalVenture · US · galil-medical.com$52MWith 2 others
  34. Nov
    Quinnova PharmaceuticalsSeries A · US$14MWith 1 other
  35. Nov
    Solstice NeurosciencesSeries B · US · solsticeneuro.com$85MWith 4 others
  36. Aug
    ZogenixSeries A · US · zogenix.com$60MWith 4 others
  37. 2005

    3 rounds

  38. Jul
    Solstice NeurosciencesVenture · US$8.0MWith 3 others
  39. Jun
    Torax MedicalSeries B · US · bizjournals.com$10MWith 2 others
  40. May
    TranzymeSeries A · USUndisclosedWith 6 others
  41. 2003

    2 rounds

  42. Oct
    OsteoBiologicsVenture · US$9.2MWith 2 others
  43. Aug
    Coley Pharmaceutical GroupVenture · US$30MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed6 in all

Auspex PharmaceuticalsBought by Teva Pharmaceutical Industries$3.2BMar 2015
InnoPharmaBought by Pfizer$225MJul 2014
ZogenixListedUndisclosedNov 2010
Solstice NeurosciencesBought by US WorldMeds$36MAug 2010
Coley Pharmaceutical GroupBought by PfizerUndisclosedNov 2007
OsteoBiologicsBought by Smith & NephewUndisclosedJul 2006

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Thomas, McNerney & Partners. A count of rooms they were both in, not a relationship either has claimed.

Investor ABVC firm6rounds togetherH.I.G. CapitalGrowth equity5rounds togetherDomain AssociatesVC firm4rounds togetherBDC CapitalVC firm3rounds togetherCMEA VenturesVC firm3rounds togetherClarus VenturesVC firm3rounds togetherQuaker PartnersVC firm3rounds togetherVenrockVC firm3rounds togetherAccuitive Medical VenturesVC firm2rounds togetherDeerfieldVC firm2rounds togetherGenesys CapitalVC firm2rounds togetherInterWest PartnersVC firm2rounds together

Quick answers about Thomas, McNerney & Partners

What does Thomas, McNerney & Partners invest in?

Thomas, McNerney & Partners invests most often at Venture and Series B (47% of the rounds on record), in sectors such as Consumer, FinTech and Finance & Crypto.

How active is Thomas, McNerney & Partners?

33 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2014.

How big are Thomas, McNerney & Partners's cheques?

The median round it joins is $17M.

Does Thomas, McNerney & Partners lead rounds?

Rarely, if at all: none of its 33 investments on record names it as the lead.

Where does Thomas, McNerney & Partners invest?

Most of the companies it backs are in the United States (100%).

Is Thomas, McNerney & Partners investing now?

No investments in the last 12 months; the latest was in Oct 2014.

Who does Thomas, McNerney & Partners invest alongside?

Most often Investor AB (6 rounds together), H.I.G. Capital (5 rounds together) and Domain Associates (4 rounds together).

What kind of investor is Thomas, McNerney & Partners?

Thomas, McNerney & Partners is a VC firm based in Stamford, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it